🇺🇸 FDA
Pipeline program

Aflibercept

EVEN Study

Approved small_molecule completed

Quick answer

Aflibercept for Submacular Vascularized Pigment Epithelial Detachments is a Approved program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Submacular Vascularized Pigment Epithelial Detachments
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials